Cite
Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.
MLA
Maki Namura, et al. “Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.” Clinical Breast Cancer, vol. 18, no. 2, Apr. 2018, pp. 1287–134. EBSCOhost, https://doi.org/10.1016/j.clbc.2017.07.001.
APA
Maki Namura, Hiroko Tsunoda, Hiroshi Yagata, Naoki Hayashi, Atsushi Yoshida, Emiko Morishita, Junko Takei, Koyu Suzuki, Hideko Yamauchi, Namura, M., Tsunoda, H., Yagata, H., Hayashi, N., Yoshida, A., Morishita, E., Takei, J., Suzuki, K., & Yamauchi, H. (2018). Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype. Clinical Breast Cancer, 18(2), 1287–134. https://doi.org/10.1016/j.clbc.2017.07.001
Chicago
Maki Namura, Hiroko Tsunoda, Hiroshi Yagata, Naoki Hayashi, Atsushi Yoshida, Emiko Morishita, Junko Takei, et al. 2018. “Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.” Clinical Breast Cancer 18 (2): 1287–134. doi:10.1016/j.clbc.2017.07.001.